Milind Javle
@JavleMilind
Hubert L and Olive Stringer Professor GI Medical Oncology and Attending Physician, MD Anderson Cancer Center
Chair, NCI Task Force Hepatobiliary Cancers
05-02-2021 03:30:48
683 Tweets
1,3K Followers
325 Following
Tinengotinib VS. Physician's Choice for Patients With FGFR-altered Cholangiocarcinoma (FIRST-308) classic.clinicaltrials.gov/ct2/show/NCT05… First phase 3 trial: FGFR-inhibitor refractory CCA open! Cholangiocarcinoma Foundation Craine’s Cholangiocarcinoma Crew Melinda Bachini MD Anderson Cancer Center AMMF ENS-CCA #TransThera #livertwitter